INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,718 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$1,818
380 sh
Mar 19, 2026Mar 20, 2026
Page 306 of 468
← PrevNext →
traded Mar 19, 2026
+1d
SEC Form 4

Evidence

20
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,907
608 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,274
684 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,486 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$5,671
1,183 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,705
774 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
TP
Toth PeterEVP, Chief Sustain & Dev Off
NEMNEWMONT Corp /DE/
Open-market sale · 10b5-1 plan
SELL$324K
3,000 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

20
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,913
608 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

19
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$187K
3,795 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

19
TD
Travers DavidPresident and interim CFO
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$60K
23.7K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

17
HJ
Hogan Michael JamesChief Business Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$78K
1,800 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

16
ST
Sakamoto Ryan T.EVP, Chief Legal Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$6,399
2,495 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

16
GA
Garefis AmyEVP, Chief People Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$6,492
2,532 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

15
RR
Reich RichardSVP and Gen Counsel
NJRNEW JERSEY RESOURCES CORP
Open-market sale · 10b5-1 plan
SELL$289K
5,449 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

15
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$1.03M
25.6K sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

13
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$687K
16.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

13
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$21K
9,722 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

13
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$23K
9,722 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

13
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$448K
10.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

12
HB
Herraiz Lizette BenediGENERAL COUNSEL
STRAStrategic Education, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
2,982 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

11
DD
Dieter DavidEVP & General Counsel
COLLCOLLEGIUM PHARMACEUTICAL, INC
Open-market sale · 10b5-1 plan
SELL$488K
14.0K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
KK
Keough KelliEVP, GBUL, SIPS
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$165K
9,742 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

5
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$180K
4,352 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

1
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$106K
2,481 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

54
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$26.94M
1.79M sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

46
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$802K
12.0K sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

46
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$284K
4,084 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

46
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$802K
11.7K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

46
ZT
Zalatoris TimmiChief Human Resources Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$784K
9,340 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

46
MA
Mottiwala AzizChief Commercial Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$298K
4,286 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

46
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$3.20M
200.0K sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

45
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$49.85M
3.21M sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

44
SA
Sfadia AdiCEO
GILTGILAT SATELLITE NETWORKS LTD
Open-market sale
SELL$632K
37.5K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

43
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Open-market sale
SELL$4.77M
102.8K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

43
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Open-market sale
SELL$2.22M
47.2K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
MA
Mottiwala AzizChief Commercial Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$298K
4,330 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$283K
4,231 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

42
SJ
Sinclair JackDirector, Chief Executive Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$397K
4,754 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$283K
4,125 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
TA
Tomasso Christopher AnthonyDirector, President and CEO
FWRGFirst Watch Restaurant Group, Inc.
Open-market sale
SELL$314K
25.1K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence